Thank you!

Your form has been submitted.
If you have any questions: 888-301-NMDX (6639) | Online Chat | Email


Stay Connected!

Don’t forget to follow us on your favorite social media.


We are excited to announce that QIAGEN has acquired all shares of NeuMoDx Molecular, Inc. The addition of NeuMoDx’s medium- and high-throughput molecular systems further expands QIAGEN’s portfolio of molecular diagnostics instruments, bolstering our leadership in automated molecular testing. We are proud to welcome NeuMoDx to our family of PCR solutions that make improvements in life possible.

To learn more, click here.